Nature Liu Lian's team from Shandong University discovered a potential new treatment for advanced gastric cancer
Time of Update: 2023-02-03
On January 3, 2023, the team of Liu Lian of Shandong University published a report entitled "Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric" online in Nature Communications cancer", which conducted a single-arm phase II exploratory trial evaluating the efficacy of ICI (camrelizumab), antiangiogenic (apatinib), and chemotherapy (S-1±oxaliplatin) in combination with cT4a/bN+ neoadjuvanc/conversion therapy for gastric cancer.
East Sunshine's first generic patent challenged the original research successfully, and fingolimod capsules were approved for marketing in the United States
Time of Update: 2022-10-25
On October 18, 2022, the US court officially ruled that the US9187405 patent was invalid, and fingolimod capsules were officially put on sale in the United States, marking East Sunshine becoming the first Chinese company to challenge the original drug patent in the United States and succeed.
Early diagnosis and early treatment of cognitive impairment after stroke is the key, come and watch the big coffee point of view
Time of Update: 2022-10-01
*For medical professionals onlyPSCI should be "early prevention, early detection, early treatment", and standardized medication helps patients recoverThe prevalence of stroke in China is 11,148/100,00
Under the tide of acquisitions in the pharmaceutical industry, leading companies are accelerating their integration
Time of Update: 2022-08-15
It is understood that the acquisition will help Chutian Technology to expand its product series; at the same time, it will further strengthen the company's competitiveness in the field of pharmaceutical equipment, and the layout of multiple industrial chains will enhance the ability to resist risks and sustainable development .
Pharmaceutical companies start a wave of cooperation again, and take the lead in the big health track
Time of Update: 2022-08-10
The two parties will rely on their respective advantageous resources to jointly develop the big health business online and offline Imperial Palace Chain & Gome Holdings A few days ago, Imperial Palace Chain under Imperial Palace officially signed a strategic cooperation agreement with Oiyo, a subsidiary of Gome Holdings.
Henan announced the sales of the top 100 pharmaceutical companies in the first quarter: Hengrui, Qilu, Chia Tai Tianqing
Time of Update: 2022-05-16
01 The ranking has changed, and domestic top pharmaceutical companies have an advantage01 The ranking has changed, and domestic top pharmaceutical companies have an advantageOn April 26, the Henan Provincial Public Resource Trading Center issued the "Notice on Publicizing the Province's Online Drug Transactions in the First Quarter of 2022" (hereinafter referred to as the "Notice") .
Alzheimers Dementia: A blood amyloid marker that predicts long-term dementia risk
Time of Update: 2022-04-21
In this large cohort of MCI subjects, they found a threshold for the plasma Aβ1-42/Aβ1-40 ratio that might identify patients at low risk of converting to dementia within 3 years .
Neurology: Association of disease-modifying antirheumatic drugs with Parkinson's disease risk
Time of Update: 2022-02-19
RDisease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis .
0000000000013303RDisease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid ArthritisLeave a Comment here
A pharmacy sells inferior drugs without fines of 100,000
Time of Update: 2022-01-01
Based on the above facts, in accordance with the relevant penal provisions of the "Regulations on the Implementation of the Drug Administration Law", the regulatory authorities impose the following penalties on pharmacies:Ordered to correct relevant illegal acts, and confiscated 55 yuan of illegal gains .
Cefdinir Dispersible Tablets, a subsidiary of Lisheng Pharmaceutical, passed the consistency evaluation of generic drugs
Time of Update: 2021-11-13
On November 5, Lisheng Pharmaceutical issued an announcement stating that its subsidiary, Central Pharmaceuticals, had recently received the "Approval for Drug Supplement" (batch number: 2021B03871) for the 0.
1g specification of cefdinir dispersible tablets issued by the National Medical Products Administration.
Centralized procurement to promote insulin and Chinese patent medicines to promote drug bidding in one place and publish new "retaliatory" regulations
Time of Update: 2021-10-22
Looking back at the first round of the first-round list of 20 key monitored drugs issued by the National Health and Medical Commission, they did not include proprietary Chinese medicines .
On September 25th, Hubei issued an announcement on the centralized procurement of the Inter-Provincial Volume Procurement Alliance of Chinese Patent Medicines .
[Guideline consensus] Expert consensus on nasal glucocorticoid treatment of allergic rhinitis (2021, Shanghai
Time of Update: 2021-10-09
A number of clinical controlled trials have shown that nasal glucocorticoids can effectively improve the nasal symptoms of patients with allergic rhinitis, including sneezing, nasal itching, runny nose and nasal congestion .
The State Food and Drug Administration released a catalog of generic drug reference preparations
Time of Update: 2021-08-05
After review and determination by the Expert Committee of the Quality and Efficacy Consistency Evaluation of Generic Drugs of the National Medical Products Administration, the catalogue of generic drug reference preparations (the 43rd batch) is now released .
Attachment: List of Generic Drug Reference Preparations (Forty-third batch)
New medicine for refractory epilepsy
Time of Update: 2021-06-08
In 2 adequate and well-controlled clinical studies, Ontozry significantly reduced the frequency of focal seizures compared with placebo, and up to 20% of patients achieved zero seizures during the maintenance period.
The original drug price pharmacy is 454% higher than the hospital drug price monitoring network spread
Time of Update: 2021-03-07
At the end of July, Weihai City Health Insurance Bureau issued a "notice on further doing a good job in monitoring pharmaceutical prices", proposed to use (business volume) large, strong public response, high social concern, medical insurance funds affected by the price of drugs, medical supplies and medical services in a timely manner into the scope of price monitoring, expanding the monitoring object and scope, and implement dynamic adjustment.